Mohd Hamzah A, Memish Ziad A, Alfaraj Sarah H, McClish Donna, Altuwaijri Talal, Alanazi Marzouqah S, Aloqiel Saleh A, Alenzi Ahmed M, Bafaqeeh Fahad, Mohamed Amal M, Aldosari Kamel, Ghazal Sameeh
Infectious Diseases Division, Department of Medicine, Prince Mohamed Bin Abdulaziz Hospital, Ministry of Health, Riyadh, Saudi Arabia.
Infectious Diseases Division, Department of Medicine, Prince Mohamed Bin Abdulaziz Hospital, Ministry of Health, Riyadh, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Travel Med Infect Dis. 2016 Sep-Oct;14(5):464-470. doi: 10.1016/j.tmaid.2016.09.008. Epub 2016 Sep 24.
A case control study to better characterize the clinical features, laboratory, and radiological abnormalities associated with MERS-CoV infection in order to help with early identification of this syndrome from other respiratory infections.
Eighty patients admitted to a hospital in Riyadh, diagnosed with MERS-CoV infection based on RT-PCR were matched on age, sex, and the presence of a co-morbid condition on a basis of 1:2 to other patients admitted with respiratory symptoms and tested negative for MERS-CoV on RT-PCR.
None of the reported MERS-CoV presenting symptoms was significantly associated with being infected with MERS-CoV. On the other hand, WBC count was significantly lower in patients with confirmed MERS-CoV infection (median 5.7 vs 9.3, P: 0.0004). Neutrophil count was as well significantly lower in MERS-CoV patients (median 3.7 vs 6.7, P: 0.0001). Both AST, and ALT values were significantly higher in MERS-CoV infected group (AST median 42 vs 36, P: 0.03, and ALT median 33 vs 28, P: 0.003). Overall our MERS-CoV mortality rate was (10%) below the national figure of (40%).
None of the presenting symptoms are specific for MERS-CoV infection. And out of all the investigations WBC, neutrophil counts, AST and ALT values have some predictive utility.
开展一项病例对照研究,以更好地描述与中东呼吸综合征冠状病毒(MERS-CoV)感染相关的临床特征、实验室及放射学异常情况,从而有助于从其他呼吸道感染中早期识别该综合征。
利雅得一家医院收治的80例经逆转录聚合酶链反应(RT-PCR)确诊为MERS-CoV感染的患者,按照年龄、性别及合并症情况以1:2的比例与其他有呼吸道症状且RT-PCR检测MERS-CoV呈阴性的住院患者进行匹配。
所报告的MERS-CoV出现的症状均与感染MERS-CoV无显著关联。另一方面,确诊为MERS-CoV感染的患者白细胞计数显著更低(中位数5.7对9.3,P:0.0004)。MERS-CoV患者的中性粒细胞计数也显著更低(中位数3.7对6.7,P:0.0001)。MERS-CoV感染组的谷草转氨酶(AST)和谷丙转氨酶(ALT)值均显著更高(AST中位数42对36,P:0.03;ALT中位数33对28,P:0.003)。总体而言,我们的MERS-CoV死亡率为(10%),低于全国(40%)的数字。
所出现的症状均非MERS-CoV感染所特有。在所有检查中,白细胞、中性粒细胞计数、AST和ALT值具有一定的预测作用。